Article -> Article Details
| Title | Metabolomics Services Market Report Analysis and Global Forecast till 2030 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Metabolomics Services Market, Metabolomics Services Market Size, Metabolomics Services Market Industry, Global Metabolomics Services Market, Metabolomics Services Market Research, |
| Owner | Vaibhav |
| Description | |
|
Metabolomics Services Market was valued USD 2.02 Billion in
2021 and is expected to reach USD 6.36 billion by 2030 at 11.92% CAGR during
the forecast period 2022-2030. Metaboliomics can be described as the study and analysis of biochemical
processes involving intermediates and by-products of metabolic activities. Such
products are known as metabolomes, which constitute the cluster of all
metabolites involved in various reactions in the organism, including signaling
molecules, secondary metabolites, metabolic intermediates, and hormones. Metabolomics
Services Market Trends and Analysis By Product
and Service, By Application - Global Forecast till 2030. Market Dynamics Metabolite analysis is widely used for early diagnosis of various
diseases such as cancer, neurological disorders, heart disease, and others.
Among the various clinical conditions, cancer is the largest contributor to the
demand for metabolomics services market. It is primarily attributed to the
global rise in cancer incidence and increasing oncological research activities.
According to the World Health Organization (WHO), cancer was the second leading
cause of deaths worldwide and responsible for 8.8 million deaths in 2015.
According to the National Cancer Institute, an estimated 1,735,350 new cases of
cancer have been diagnosed in the US in 2018. The global metabolomics services
market is driven by a rise in the use of metabolomics in precision
medicine and the advent of diagnostic testing for the diagnosis of chronic
diseases. Moreover, technological developments in analytical techniques and an
increase in R&D expenditure are expected to fuel market growth. Major Key
Players: The Metabolomics Services Market Players are Waters (US), Agilent
Technologies, Inc. (US), Bruker (US), TMIC (Canada), Thermo Fisher Scientific
(US), Biocrates Life Sciences AG (Austria), Creative Proteomics (US),
Metabolon, INC (US), Human Metabolome Technologies America Inc (Japan), and Shimadzu
Corporation (Japan). Innovation, product growth, and acquisition & mergers
were some of the main strategies pursued by players operating on the global
metabolomics services market. Segment Analysis The global demand for metabolomics services is segmented into products
and services, and applications. The demand for baby products and services has been segmented into chromatography,
metabolic bioinformatics
services and mass spectrometry. Based on the application, the global market for metabolomics services
has been segmented into the biomedical and pharmaceutical, agriculture, and
food industries. Regional Analysis The global metabolomics services
market report, based on region, is divided into the Americas, Europe, the Asia
Pacific, and the Middle East & Africa. The Americas are expected to have the largest share of the global market
in services to metabolomics. Americas development can be related due to the
increasing prevalence of cancer and cardiovascular diseases. It is projected
that 1,762,450 new cancer cases will be diagnosed in the US in 2019, according
to the American Cancer Society, Inc. Due to estimates from the National
Institutes of Health for 2018, the number of cancer cases and the number of
patients will both rise to 23.6 million by 2030. Europe is expected to have the second-largest market share in the
forecast period. The European market for metabolic services is further divided
into Western Europe and Eastern Europe. Western Europe is further divided into
Germany, the United Kingdom, Italy, Spain, France, and the rest of Western
Europe. The factors responsible for the growth of the market in this area are
the presence of a large number of medical device companies, increased spending
on health care, and innovation in medical devices to improve quality of life. The Asia Pacific is expected to be the fastest-growing market due to the
evolving healthcare infrastructure, increasing numbers of R&D organizations
and rising disposable revenue. In addition, the growth of research and development
centers and the entry of top companies in developed countries are boosting
market growth in this region. Due to factors such as low per capita income, the Middle East &
Africa are projected to show the least growth on the global metabolomics services
sector, and lack of sufficient funding for healthcare infrastructure accounted
for a comparatively smaller market share in 2018. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 | |